Sota Asaga
Overview
Explore the profile of Sota Asaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakai T, Kutomi G, Shien T, Asaga S, Aruga T, Ishitobi M, et al.
Breast Cancer
. 2023 Oct;
31(1):1-7.
PMID: 37843765
The 2022 revision of the Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for surgical treatment of breast cancer was updated following a systematic review of the literature using the...
2.
Adachi Y, Asaga S, Kumamaru H, Kinugawa N, Sagara Y, Niikura N, et al.
Breast Cancer Res Treat
. 2023 Jul;
201(3):397-408.
PMID: 37479943
Purpose: Many studies have shown that the prognosis of invasive lobular carcinoma (ILC) is better than that of invasive ductal carcinoma (IDC). However, both disorders exhibit different prognoses according to...
3.
Tada K, Kumamaru H, Miyata H, Asaga S, Iijima K, Ogo E, et al.
Breast Cancer
. 2022 Dec;
30(2):157-166.
PMID: 36547868
Information regarding patients who were treated for breast cancer in 2018 was extracted from the National Clinical Database (NCD), which is run by Japanese physicians. This database continues from 1975,...
4.
Aihara T, Kumamaru H, Ishitobi M, Miyashita M, Miyata H, Tamura K, et al.
Breast Cancer Res Treat
. 2022 Oct;
196(3):635-645.
PMID: 36273358
Purpose: We aimed to determine the prognosis and potential benefit of postoperative chemotherapy according to subtype of medullary breast carcinoma (MedBC), a very rare invasive breast cancer. Methods: A cohort...
5.
Hayashida T, Odani E, Kikuchi M, Nagayama A, Seki T, Takahashi M, et al.
Cancer Sci
. 2022 Jul;
113(10):3528-3534.
PMID: 35880248
Although the categorization of ultrasound using the Breast Imaging Reporting and Data System (BI-RADS) has become widespread worldwide, the problem of inter-observer variability remains. To maintain uniformity in diagnostic accuracy,...
6.
Yamada A, Hayashi N, Kumamaru H, Nagahashi M, Usune S, Asaga S, et al.
Eur J Cancer
. 2022 Jun;
172:31-40.
PMID: 35752154
Aim: Postmastectomy radiotherapy (PMRT) is the standard treatment for locally advanced breast cancer. However, the effectiveness of PMRT in patients with pT1-2 and N1 tumours remains controversial. Therefore, this study...
7.
Shimomura A, Nagahashi M, Kumamaru H, Aogi K, Asaga S, Hayashi N, et al.
Breast Cancer
. 2022 Jun;
29(6):985-992.
PMID: 35733033
Background: Male breast cancer (MBC) is rare; however, its incidence is increasing. There have been no large-scale reports on the clinicopathological characteristics of MBC in Japan. Methods: We investigated patients...
8.
Terada M, Miyashita M, Kumamaru H, Miyata H, Tamura K, Yoshida M, et al.
Breast Cancer
. 2022 Mar;
29(4):698-708.
PMID: 35316446
Background: Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition...
9.
Asaga S, Tsuchiya A, Ishizaka Y, Miyamoto K, Ito H, Isaka H, et al.
Int J Clin Oncol
. 2021 Apr;
26(8):1461-1468.
PMID: 33877488
Background: Sentinel lymph node biopsy is widely applied for the management of clinically node-negative breast cancer, and a radioisotope with a blue dye are most often used as tracers. Fluorescence...
10.
Hayashi N, Kumamaru H, Isozumi U, Aogi K, Asaga S, Iijima K, et al.
Breast Cancer
. 2020 Jul;
27(5):803-809.
PMID: 32710374
Background: The Japanese Breast Cancer Society Registry started in 1975; it was transferred to the registry platform of the National Clinical Database in 2012. We provide the annual data and...